NRX Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
NRX Pharmaceuticals, Inc. (NRXP) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $1.09 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2026-08-14
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $1.09K.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $147.00; Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value as first filed $147.00K.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $365.00; Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value as first filed $365.00K.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $0.00.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value as first filed |
|---|---|---|
| 2026-06-30 | $1.09K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $147.00 10-Q · filed 2026-08-14 | $147.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $365.00 10-Q · filed 2026-08-14 | $365.00K 10-K · filed 2026-03-23 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-08-18 | |
| 2024-12-31 | $0.00 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-11-14 | |
| 2024-03-31 | $40.00K 10-Q · filed 2024-11-14 | |
| 2023-12-31 | $75.00K 10-K · filed 2026-03-23 | |
| 2023-09-30 | $10.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $46.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $124.00K 10-Q · filed 2023-08-14 | |
| 2022-12-31 | $2.55M 10-K · filed 2024-03-29 | |
| 2022-09-30 | $278.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $174.00K 10-Q · filed 2022-11-14 | |
| 2022-03-31 | $1.01M 10-Q · filed 2022-11-14 | |
| 2021-12-31 | $4.22M 10-K · filed 2023-03-31 | |
| 2021-06-30 | $20.56M 10-Q/A · filed 2022-08-12 | |
| 2020-12-31 | $53.66M 10-K · filed 2023-03-31 | $53.66M 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |